| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |